Samsung says the IHRN system will work in tandem with the existing ECG feature on compatible Galaxy Watch models to actively assess heart activity. Just like Apple’s smartwatches, Samsung’s offerings also keep a log of irregular heart rhythm events, which could very well be a sign of serious cardiac conditions like atrial fibrillation (AFib). The company says AFib is nothing short of a “warning sign for major cardiovascular issues that can increase the risk of stroke, heart failure and other cardiovascular complications.”
At the heart of the IHRN capability on Samsung’s smartwatches is the company’s BioActive Sensor, which provides access to capabilities like heart rate alarm for abnormally low or high heart activity, and on-demand electrocardiogram (ECG) analysis. Do keep in mind that the latter is not a substitute for medical-grade ECG analysis, and its results must always be followed by consultation with a certified expert before interpreting or taking any medical action.
On the bright side, Samsung must be given credit for arming its smartwatches with another capability that opens a new avenue for heart health monitoring. Plus, it also comes as a sweet surprise that Samsung won’t be limiting it to the next-gen smartwatches, and will be later on extending the feature to models that are at least two generations old. However, if you live outside the U.S., the IHRN feature’s availability on older models is not guaranteed, and will depend on the local regulatory clearance situation.
For all the latest Gaming News Click Here
For the latest news and updates, follow us on Google News.
